CClinicalTrials.gg
CompletedNCT04266444MEFAUpdated Sep 30, 2021

Functional Exercise in Virtual Environment for Persons With Multiple Sclerosis or Parkinson's Disease

An interventional study of Exergaming in virtual environment in Parkinson Disease and Multiple Sclerosis, sponsored by University Rehabilitation Institute, Republic of Slovenia. Completed at 1 site in Slovenia. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2021-09-30.

Sponsored by University Rehabilitation Institute, Republic of Slovenia · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
108
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The aim of the study is to optimise the hand dexterity exercising program in virtual reality (VR) for patients with multiple sclerosis and Parkinson's disease. Little research has been published on this topic, but the preliminary results are promising. Different levels of difficulty of a VR game will be tested. The patients will be assessed using neuropsychological tests of executive functions, visuospatial abilities, mental speed, flexibility and motor speed. Functional ability, coordination and cognitive abilities will also be assessed.

Read the detailed description

Each patient meeting the inclusion criteria will be randomised to one of the four groups (i.e., 10cubes game difficulty level). The patients will perform five exergaming sessions, each session lasting for 1 hour, on five consecutive working days within the period of two weeks. The 10cubes task requires that all 10 cubes are moved within 2 minutes. Each patient will perform the task 5 times in succession with 1-2 minute breaks. The patients will be assessed using the Box \& Blocks Test, Frontal Assessment Battery (FAB), Delis-Kaplan Executive Function System (D-KEFS) and Judgment of Line Orientation (JLO) before the first session and after the last session. In addition, the patients will fill in the Intrinsic Motivation Inventory (IMI) after each session. Based on statistical sample size calculations, the study plan is to include 80 patients with Parkinson's disease and 12 patients with multiple sclerosis randomising them separately, so that the groups will be balanced in terms of size and diagnosis.

02

Conditions studied

  • Parkinson Disease
  • Multiple Sclerosis

Keywords

  • exergaming
  • virtual reality
  • neuropsychological tests
  • motivation
03

In context

Parkinson Disease

4,487 studies on the registry are indexed under Parkinson Disease; 1,082 are open to participants now.

This study's enrollment of 108 is above the median of 40 across 3,294 interventional studies indexed under Parkinson Disease.

Browse Parkinson Disease studies →

Lead sponsor

University Rehabilitation Institute, Republic of Slovenia is the lead sponsor of 21 studies on the registry; 7 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • diagnose of Parkinson's disease or multiple sclerosis;
  • Mini Mental State Examination score above 24;
  • preserved upper limb function;
  • for Parkinson's disease patients Hoehn and Yahr scale score between 2 and 3.

Exclusion criteria

Exclusion Criteria:

  • any communicable disease;
  • severe vision impairment.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
108 participants (actual)

Study arms

  • Active comparator
    Level 4

    10Cubes game in virtual reality using very small bouncing blocks

    Device: Exergaming in virtual environment

  • Active comparator
    Level 3

    10Cubes game in virtual reality using very small non-bouncing blocks

    Device: Exergaming in virtual environment

  • Active comparator
    Level 2

    10Cubes game in virtual reality using large bouncing blocks

    Device: Exergaming in virtual environment

  • Active comparator
    Level 1

    10Cubes game in virtual reality using large non-bouncing blocks

    Device: Exergaming in virtual environment

Interventions

  • DeviceExergaming in virtual environment

    The 10Cubes game (by I. Cikajlo) will be used. In the game, the motion of the hand, wrist and fingers is tracked by an infra-red camera (by LeapMotion, Inc.) and hand motion is reflected in the virtual environment. The software will run on a powerful computer with a 19" display. Each group will have the game set to a different level of difficulty.

06

What researchers measure

Primary outcomes

  1. Change in Box & Blocks Test from baseline

    Standard clinical test to assesses unilateral gross manual dexterity; the minimum possible score is 0, the maximum is 150; higher score indicates better outcome.

    Time frame: Assessment at baseline and after two weeks

  2. Change in Frontal Assessment Battery (FAB) score from baseline

    Brief neuropsychological test battery to assess executive functions; the minimum possible score is 0, the maximum is 18; higher score indicates better outcome.

    Time frame: Assessment at baseline and after two weeks

  3. Intrinsic Motivation Inventory (IMI) scores

    The IMI is a multidimensional measurement instrument for assessing subjective experience of a target activity. The 22-item version that consists of four subscales will be used (scores range from 7 to 49 for one scale and from 5 to 35 for three scales); higher scores indicate better outcome.

    Time frame: Assessment at the end of each exergaming session; median across assessments will be taken as the outcome on each subscale

Secondary outcomes

  1. Change in Delis-Kaplan Executive Function System (D-KEFS) scores from baseline

    Set of nine subtests of executive functions with complex computerised scoring; higher scores indicate better outcome.

    Time frame: Assessment at baseline and after two weeks

  2. Change in Judgment of Line Orientation (JLO)

    Standardized test of visuospatial skills; the minimum possible score is 0, the maximum is 30; higher score indicates better outcome.

    Time frame: Assessment at baseline and after two weeks

07

Study locations

1 site
  • University Rehabilitation Institute, Republic of Slovenia
    Ljubljana, 1000, Slovenia
08

References and documents

Publications

  • Cikajlo I, Peterlin Potisk K. Advantages of using 3D virtual reality based training in persons with Parkinson's disease: a parallel study. J Neuroeng Rehabil. 2019 Oct 17;16(1):119. doi: 10.1186/s12984-019-0601-1. PubMed 31623622 ↗
  • Cikajlo I, Hukic A, Udovcic Pertot A. The size and behavior of virtual objects have influence on functional exercise and motivation of persons with multiple sclerosis: a randomized study. Sci Rep. 2022 Nov 12;12(1):19375. doi: 10.1038/s41598-022-24046-3. PubMed 36371421 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 30, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04266444
Lead sponsor
University Rehabilitation Institute, Republic of Slovenia
Responsible party
Sponsor
First posted
Feb 12, 2020
Start date
Feb 6, 2020
Primary completion
Sep 29, 2021
Completion
Sep 29, 2021
Last update
Sep 30, 2021

Study contacts

Imre Cikajlo, PhD
principal investigator · University Rehabilitation Institute, Republic of Slovenia

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion